Department of Medicine: Hematology/Oncology, Massachusetts General Hospital, Boston, MA.
Transfus Med Rev. 2018 Oct;32(4):225-229. doi: 10.1016/j.tmrv.2018.08.004. Epub 2018 Aug 23.
Thrombocytopenia is a common hematologic issue encountered by obstetricians and hematologists, detected in about 10% of all pregnancies. In the vast majority of cases, the thrombocytopenia will be attributed to gestational thrombocytopenia (GT), where the thrombocytopenia is mild, does not necessitate active management, and does not introduce maternal or fetal bleeding risk. Although GT is common, the specific mechanism responsible for it is not known with certainty, and therefore, differentiating it from other causes of thrombocytopenia can be challenging. Previously proposed explanations for GT suggest that a decrease in platelet count is universal in pregnancy, and women diagnosed with GT are simply those with a baseline platelet count on the lower end of normal range. This concept is challenged in this review, and a possible mechanism for GT is proposed. Additionally, a framework for approaching the diagnosis and management of thrombocytopenia in pregnancy is presented.
血小板减少症是产科医生和血液学家经常遇到的一种常见血液学问题,约 10%的妊娠都会出现这种情况。在绝大多数情况下,血小板减少症将归因于妊娠相关性血小板减少症(GT),其血小板减少症程度较轻,不需要积极治疗,也不会增加母体或胎儿出血的风险。尽管 GT 很常见,但导致其发生的确切机制尚不能完全确定,因此,区分 GT 与其他原因引起的血小板减少症可能具有挑战性。先前提出的 GT 解释表明,妊娠期间血小板计数普遍下降,而被诊断为 GT 的女性只是那些血小板计数处于正常范围较低端的女性。这一概念在本综述中受到挑战,并提出了 GT 的一种可能机制。此外,还提出了一种用于诊断和管理妊娠期间血小板减少症的方法框架。